Cargando…
Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
Innovative immunotherapies based on immune checkpoint targeting antibodies and engineered T cells are transforming the way we approach cancer treatment. However, although these T cell centered strategies result in marked and durable responses in patients across many different tumor types, they provi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586996/ https://www.ncbi.nlm.nih.gov/pubmed/32620049 http://dx.doi.org/10.1002/JLB.1MR0520-746R |